NO751455L - - Google Patents

Info

Publication number
NO751455L
NO751455L NO751455A NO751455A NO751455L NO 751455 L NO751455 L NO 751455L NO 751455 A NO751455 A NO 751455A NO 751455 A NO751455 A NO 751455A NO 751455 L NO751455 L NO 751455L
Authority
NO
Norway
Prior art keywords
formula
compounds
stands
substituents
meaning
Prior art date
Application number
NO751455A
Other languages
Norwegian (no)
Inventor
G B Bennett
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO751455L publication Critical patent/NO751455L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Description

Foreliggende oppfinnelse vedrorer en fremgangsmåte for fremstilling av nye 5,5,7,7-tetrametylfuro(3,4-e)as-triaziner med formel I The present invention relates to a process for the production of new 5,5,7,7-tetramethylfuro(3,4-e)as-triazines of formula I

hvori X står for og og R 2 er like eller forskjellige og betyr i det enkelte tilfelle hydrogen, fluor, klor, en alkylgruppe med 1-4 karbonatomer, en rettkjedet alkoksygruppe med 1-4 karbonatomer, amino, nitro eller trifluormetyl, med den betingelse at (I) hvis en av substituentene og R£betyr nitro har den annen av disse substituenter en annen betydning enn nitro eller trifluormetyl, (II) hvis en av substituentene R^og R2står for t-butyl eller trifluormetyl, står den annen av disse substituenter, hvis den befinner seg på det nabostående karbonatom, ikke for trifluormetyl eller t-butyl, og (III) hvis en av substituentene R, og R_ står for t-butyl, står den annen av disse substituenter, hvis den befinner seg. på det nabostående karbonatom, ikke for nitro. in which X stands for and and R 2 are the same or different and mean in each case hydrogen, fluorine, chlorine, an alkyl group with 1-4 carbon atoms, a straight-chain alkoxy group with 1-4 carbon atoms, amino, nitro or trifluoromethyl, with the condition that (I) if one of the substituents and R£ means nitro, the other of these substituents has a different meaning than nitro or trifluoromethyl, (II) if one of the substituents R^ and R2 stands for t-butyl or trifluoromethyl, the other of these substituents, if it is on the neighboring carbon atom, not for trifluoromethyl or t-butyl, and (III) if one of the substituents R, and R_ stands for t-butyl, the other of these substituents, if present. on the neighboring carbon atom, not for nitro.

Forbindelsene med formel I kan overfores i sine syreaddisjonssalter og omvendt. The compounds of formula I can be transferred in their acid addition salts and vice versa.

Det særegne ved fremgangsmåten er atThe peculiarity of the procedure is that

a) for fremstilling av forbindelser med formel Ia,a) for the preparation of compounds of formula Ia,

hvori R^ og R£ har den ovennevnte betydning, omsettes en in which R^ and R£ have the above-mentioned meaning, a is converted

forbindelse med formel IIcompound of formula II

i en inert gassatmosfære med forbindelser med formel III hvori R^ og R£ har den ovennevnte betydning og R^står for metyl eller etyl, éiler b) for fremstilling av forbindelser med formel Iaa hvori R1' står for hydrogen, fluor, k&or, en alkylgruppe med 1-4 karbonatomer, eller en rettkjedet alkoksygruppe med 1-4 karbonatomer eller står for amino, med den betingelse at ' har en annen betydning enn t-butyl, hvis den befinner seg på det karbonatom som er nabostående til nitrogruppen, ved at forbindelser med formellab in an inert gas atmosphere with compounds of formula III in which R^ and R£ have the above meaning and R^ stands for methyl or ethyl, éiler b) for the preparation of compounds of formula Iaa in which R1' stands for hydrogen, fluorine, carbon, a alkyl group with 1-4 carbon atoms, or a straight-chain alkoxy group with 1-4 carbon atoms or stands for amino, with the proviso that ' has a different meaning than t-butyl, if it is located on the carbon atom adjacent to the nitro group, in that compounds with formula lab

hvori R^1 har den ovennevnte betydning, nitreres eller wherein R^1 has the above meaning, is nitrated or

c) forbindelse med formel Ib,c) compound of formula Ib,

hvori R^og R£har den ovennevnte betydning, fremstilles ved at in which R^ and R£ have the above meaning, is produced by at

N-oksydgruppen i forbindelsene med formel Ia reduseres i inert-gassatmo.sfære. The N-oxide group in the compounds of formula Ia is reduced in an inert gas atmosphere.

Den under a) angitte fremgangsmåte kan gjennomfbres søm beskrevet i det fblgende: Omsetningen av forbindelsene med formel II med forbindelsene med formel III kan hensiktsmessig gjennomfbres ved temperaturerspå 70 til 200°C, foretrukket 130 til 150°C, idet reaksjonstidene f.eks. kan utgjore 12 til 36 timer, spesielt 15 til 20 timer. Omsetningen skjer hensiktsmessig i et inert organisk løsnings-middel, f.eks. aromatiske hydrokarboner som benzen eller toluen, og lavere alkanoler som metanol eller etanol. I stedet for inerte organiske løsningsmidler kan likeledes et overskudd av forbindelsene med formel III velges som reaksjonsmedium. Den inérte gassatmosfære består f.eks. av helium, argon eller foretrukket nitrogen. The method indicated under a) can be carried out as described in the following: The reaction of the compounds of formula II with the compounds of formula III can conveniently be carried out at temperatures of 70 to 200°C, preferably 130 to 150°C, the reaction times e.g. can amount to 12 to 36 hours, especially 15 to 20 hours. The reaction conveniently takes place in an inert organic solvent, e.g. aromatic hydrocarbons such as benzene or toluene, and lower alkanols such as methanol or ethanol. Instead of inert organic solvents, an excess of the compounds of formula III can likewise be chosen as reaction medium. The inert gas atmosphere consists of e.g. of helium, argon or preferably nitrogen.

Den under b) angitte fremgangsmåte kan gjennomfbres som beskrevet i det fblgende: Nitreringen av forbindelsene med formel lab skjer på i og for seg kjent måte under anvendelse av vanlige nitronium-ioner dannende reagenser, f.eks. en blanding av svovelsyre og salpetersyre, The method indicated under b) can be carried out as described in the following: The nitration of the compounds of formula lab takes place in a manner known per se using common reagents forming nitronium ions, e.g. a mixture of sulfuric acid and nitric acid,

en blanding av trifluormetansulfonsyre og rykende salpetersyre, eller en blanding av hydrogenfluorid og .dinitrogenperoksyd i nitrometan (ved -20°C). Det foretrukne nitreringsmiddel er imidlertid en blanding av trifluormetansyre og rykende salpetersyre, foretrukket i et molforhold på 2:1. Nitreringen skjer hensiktsmessig i et inert organisk'løsningsmiddel. Egnede løsningsmidler er aromatiske hydrokarboner som metylenklorid eller kloroform, foretrukket metylenklorid. a mixture of trifluoromethanesulfonic acid and fuming nitric acid, or a mixture of hydrogen fluoride and dinitrogen peroxide in nitromethane (at -20°C). However, the preferred nitrating agent is a mixture of trifluoromethane acid and fuming nitric acid, preferably in a molar ratio of 2:1. The nitration conveniently takes place in an inert organic solvent. Suitable solvents are aromatic hydrocarbons such as methylene chloride or chloroform, preferably methylene chloride.

ReaksjoiSbemperaturen utgjor hensiktsmessig fra -80 til +70°C, foretrukket fra -35 til +35°C og reaksjonstiden kan f.eks. utgjore fra 19 til 76 timer, spesielt fra 60 til 75 timer. The reaction temperature is suitably from -80 to +70°C, preferably from -35 to +35°C and the reaction time can e.g. perform from 19 to 76 hours, especially from 60 to 75 hours.

Den under c) angitte fremgangsmåte kan gjennomfbres som beskrevet i det fblgende: The procedure specified under c) can be carried out as described in the following:

Reduksjonen av N-oksydgruppen i forbindelsene med formel Ia kan f.eks. skje under anvendelse av forbindelser med formel IV The reduction of the N-oxide group in the compounds of formula Ia can e.g. take place using compounds of formula IV

hvori Z står for klor, brom eller en alkoksygruppe med it-4 karbonatomer. For denne reaksjon egnede løsningsmidler er f.eks. aromatiske hydrokarboner som benzen eller toluen, eller foretrukket et overskudd av forbindelser med formel IV. in which Z stands for chlorine, bromine or an alkoxy group with it-4 carbon atoms. Solvents suitable for this reaction are e.g. aromatic hydrocarbons such as benzene or toluene, or preferably an excess of compounds of formula IV.

Egnede reaksjonstemperaturer utgjor fra 100 til 210°C/foretrukket fra 140 til 180°C, og reaksjonstiden kan f.eks. utgjore fra 12 til 36 timer, spesielt fra 15 til 20 timer. I stedet for.de ovennevnte forbindelser med formel IV anvender man i fremgangsmåten c) foretrukket syklohexen i nærvær av en katalysator, spesielt en edelmetallkatalysator, som platina, rhodium eller foretrukket palladium, idet disse edelmetaller enten anvendes rene eller på en bærer, f .eks. en bærer av kull, og et av de ovennevnte løsningsmidler. Omsetningen skjer hensiktsmessig ved temperaturer fra 20 til 200°C, foretrukket fra 70 til 110°C, og reaksjonstiden kan f.eks. utgjore fra 5 til 72 timer, spesielt 15 til 30 timer. Egnede ^Løsningsmidler er lavere alkanoler som Suitable reaction temperatures are from 100 to 210°C/preferably from 140 to 180°C, and the reaction time can e.g. perform from 12 to 36 hours, especially from 15 to 20 hours. Instead of the above-mentioned compounds of formula IV, cyclohexene is preferably used in method c) in the presence of a catalyst, especially a noble metal catalyst, such as platinum, rhodium or preferably palladium, these noble metals being either used pure or on a carrier, e.g. . a carrier of carbon, and one of the above-mentioned solvents. The reaction conveniently takes place at temperatures from 20 to 200°C, preferably from 70 to 110°C, and the reaction time can e.g. make from 5 to 72 hours, especially 15 to 30 hours. Suitable ^Solvents are lower alkanols which

metanol eller etanol, foretrukket den sistnevnte. Den i dénne methanol or ethanol, preferably the latter. The one in this one

fremgangsmåtenanvendte inertgassatmosfære er f.eks. én helium-, process-used inert gas atmosphere is e.g. one helium-,

argon- eller foretrukket nitrogen-atmosfære.argon or preferably nitrogen atmosphere.

De véd de ovennevnte fremgangsmåter erholdte forbindelser med formel I kan isoleres og renses på i og for seg kjent måte. The compounds of formula I obtained by the above-mentioned methods can be isolated and purified in a manner known per se.

Forbindelsene med formel I utmerker seg iwred en overordentlig gunstig farmakodynamisk virkning. Spesielt har forbindelsene med formel I en sdvnutlosende og en lett beroligende virkning, påvist f.eks. med resultater av prover som ble beskrevet av Winter i J. Pharm, and Exp. Therap. 94, 7-11 (1948), av S. Irwin (Gordon Research Conference, Medicinal Chemistry, 1959) av Chen (Symposium on Sedative and Hypnotic drugs, Williams and Wilkins, 1954) av Reed-Muench (American Journal of Hygiene 27, 493-497, (1938)) og av I. Geiler, (Psychopharmacologia, I, 42-492 (1960)). The compounds of formula I are distinguished by an extremely favorable pharmacodynamic effect. In particular, the compounds of formula I have a sedative and mild sedative effect, demonstrated e.g. with results of tests described by Winter in J. Pharm, and Exp. Therap. 94, 7-11 (1948), by S. Irwin (Gordon Research Conference, Medicinal Chemistry, 1959) by Chen (Symposium on Sedative and Hypnotic drugs, Williams and Wilkins, 1954) by Reed-Muench (American Journal of Hygiene 27, 493-497, (1938)) and by I. Geiler, (Psychopharmacologia, I, 42-492 (1960)).

Forbindelsene med formel I kan derfor anvendes for innsovning og som svakt beroligende middel. Den for sbvninnledningen tilforte dose skal utgjore fra 35 til 750 mg som hensiktsmessig tilfores i en porsjon ved sengetid. For anvendelse som svakt beroligende mitddel skal forbindelsene med formel I tilfores i en daglig dose på 75 til 1000 mg, hensiktsmessig i mindre doser fra 18 til 500 mg 2 til 4 ganger daglig eller i retardform. The compounds of formula I can therefore be used to induce sleep and as a mild sedative. The dose given for the sbv introduction should be from 35 to 750 mg, which is suitably given in one portion at bedtime. For use as a mild sedative, the compounds of formula I must be administered in a daily dose of 75 to 1000 mg, suitably in smaller doses from 18 to 500 mg 2 to 4 times a day or in retarded form.

Forbindelsene med formel I blandes hensiktsmessig sammen med vanlige.farmasoytisk- tålbare fortynningsmidler eller bærestoffer og eventuelt også.andre tilsetninger og tilfores i form av The compounds of formula I are suitably mixed together with usual pharmaceutical-tolerable diluents or carriers and possibly also other additives and supplied in the form of

tabletter eller kapsler.tablets or capsules.

Forbindelsene med formel I kan tilfores i form av de fri baser eller i form av déres f armasbytask; .tålbare syreaddisjonssalter, The compounds of formula I can be supplied in the form of the free bases or in the form of their framsbytask; .tolerable acid addition salts,

idet virkningen av saltene er av den samme stbrrelsesordnenas the effect of the salts is of the same principle

som virkningen av basene^ For saltdannelse egnede syrer er spesielt mineralsyrer:som saltsyre, brom, hydrogensyre og svovelsyre, og organiske syreæ som.ravsyre, benzosyre og maleinsyre. as the action of the bases^ Acids suitable for salt formation are especially mineral acids: such as hydrochloric, bromic, hydrogen and sulfuric acids, and organic acids such as succinic, benzoic and maleic acids.

De foretrukne forbindelser med formel I er dem hvori betyr en nitrogruppe i meta-stlling og spesielt dem hvori R står for hydrogen. The preferred compounds of formula I are those in which a nitro group is in the meta position and especially those in which R stands for hydrogen.

Eksempel 1: 5, 7- dihydro- 5, 5, 7, 7- tetrametyl- 3- fenyl- furo Example 1: 5,7-dihydro-5,5,7,7-tetramethyl-3-phenyl-furo

( 3, 4- e)- as- triazin- 4- oksyd.( 3, 4-e)- as- triazine- 4- oxide.

En blanding av 6,84 g 2,2-5,5-tetrame£yl-3,4(2H,5H)-furandion-3-hydrazon~4-oxim og 15 ml trietylortobenzoat oppvarmes i- ' nitrogenatmosfære i 18 timer til koking ved en badtemperatur på 140°C. Beretter oppvarmes dsn erholdte lbsning videre i 8 timer ved en badtemperatur. hvor de flyktige bestanddeler av-destilleres. Den tilbakeblivende blanding avkjbles til 25°C A mixture of 6.84 g of 2,2-5,5-tetramethyl-3,4(2H,5H)-furandione-3-hydrazone-4-oxime and 15 ml of triethyl orthobenzoate is heated in a nitrogen atmosphere for 18 hours to boiling at a bath temperature of 140°C. The solution obtained is further heated for 8 hours at a bath temperature. where the volatile components are distilled off. The remaining mixture is cooled to 25°C

og tilsettes £00 ml eter. Det dannede bunnfall frafiltteres og filtratet inndampes til tbrrhet i vakuum ved 100°C. Den erholdte rest loses i eter og gjennomllbsningen ledes hydrogen- - kloridgass til metning. Helved utfelles 5,7-dihydro-5,5,7,7- and £00 ml of ether is added. The precipitate formed is filtered off and the filtrate is evaporated to dryness in vacuum at 100°C. The residue obtained is dissolved in ether and hydrogen chloride gas is passed through the solution until saturation. Hell precipitates 5,7-dihydro-5,5,7,7-

tetrametyl-3-fenylfuro(3,4-e)as-triazih-4-oksyd i form av sitt hydroklorid med smeltepunkt 154-156°C. tetramethyl-3-phenylfuro(3,4-e)as-triazih-4-oxide in the form of its hydrochloride with a melting point of 154-156°C.

Eksempel 2: 5, 7- dihydro- 5, 5, 7, 7- tetrametyl- 3-( m- nitrofenyl) Example 2: 5,7-dihydro-5,5,7,7-tetramethyl-3-(m-nitrophenyl)

furo( 3, 4- e)- as- triazin- 4- oksyd.furo(3,4-e)-as-triazine-4-oxide.

En blanding av 6,84 g 2,2,5,5-tetrametyl-3,4(2H,5H)-furandion-3-hydrazon-4-oxim og 16,14 g iri-nitrotrietyl-ortobenzoat oppvarmes under nitrogen i 24 timer ved den badtemperatur på 140°C. Deretter avkjoles blandingen til 25°C og tilsettes 250 ml eter. Det dainaae bunnfalr f raf ilticeres og filtratet inndampes i vakuum ved 100°C. Resten omkrystalliseres fra metylenklorid/hexan hvorved 5,7-dihydro-5,5,7,7-tetrametyl-3-(m-nitrofenyl)furo (3,4-e)-as-triazin-4-oksyd med smeltepunkt 202-204°C erholdes. A mixture of 6.84 g of 2,2,5,5-tetramethyl-3,4(2H,5H)-furandione-3-hydrazone-4-oxime and 16.14 g of iri-nitrotriethyl orthobenzoate is heated under nitrogen for 24 hours at the bath temperature of 140°C. The mixture is then cooled to 25°C and 250 ml of ether is added. The resulting precipitate is filtered off and the filtrate is evaporated in vacuo at 100°C. The residue is recrystallized from methylene chloride/hexane whereby 5,7-dihydro-5,5,7,7-tetramethyl-3-(m-nitrophenyl)furo (3,4-e)-as-triazine-4-oxide with melting point 202- 204°C is obtained.

Eksempel 3: 5, 7- dihydro- 5, 5, 7, 7- tetrametyl- 3-( m- nitrofenyl) Example 3: 5,7-dihydro-5,5,7,7-tetramethyl-3-(m-nitrophenyl)

furo( 3, 4- e)- as- triazin- 4- oksyd.furo(3,4-e)-as-triazine-4-oxide.

En blanding av 0,2 ml rykende salpetersyre og 1,5 g trifluormetansulfonsyre i 15'ml vannfritt metylenklorid omrbres i 1 A mixture of 0.2 ml of fuming nitric acid and 1.5 g of trifluoromethanesulfonic acid in 15 ml of anhydrous methylene chloride is stirred in 1

time ved 25°C og innfores deretter dråpevis i en lbsning av 0,542 g 5,7-dihydro-5,5,7,7atetrametyl-3-fenylfuro(3,4-e)-as triazin-4-oksyd i 15 ml vannfritt metylenklorid ved -30°C. hour at 25°C and then introduced dropwise into a solution of 0.542 g of 5,7-dihydro-5,5,7,7atetramethyl-3-phenylfuro(3,4-e)-as triazine-4-oxide in 15 ml anhydrous methylene chloride at -30°C.

Den erholdte heterogene blafiding omrbres véd 25°G, % 72 'timer, utrystes deretter på is og nøytraliseres med fast natriumbi-karbonat. Det organiske skikt fjernes og det vandige skikt ekstraheres flere ganger med metylenklorid. De forenede "• organiske skikt vaskes med mettet vandig natriumkloridlbsning, tbrres over magnesiumsulfat og inndampes deretter. Herved erholdes eh hvit rest som omkrystalliseres fra metylenklorid/ hexan. Det erholdte 5,7-dihydro-5,5,7,7-tetrametyl-3-(m-nitrofenyl)-furo(3,4-e)-as-triazin-4-oksyd smelter ved 202-204°C. The obtained heterogeneous mixture is heated at 25°C for 72 hours, then shaken on ice and neutralized with solid sodium bicarbonate. The organic layer is removed and the aqueous layer is extracted several times with methylene chloride. The combined "• organic layers are washed with saturated aqueous sodium chloride solution, passed over magnesium sulfate and then evaporated. This gives a white residue which is recrystallized from methylene chloride/hexane. 5,7-dihydro-5,5,7,7-tetramethyl-3 -(m-nitrophenyl)-furo(3,4-e)-as-triazine-4-oxide melts at 202-204°C.

Eksempel 4; 5, 7- dihydro- 5, 5, 7 , 7- tetrametyl- 3- fenyl- fuco( 3, 4- e)-as- triazin. Example 4; 5, 7- dihydro- 5, 5, 7 , 7- tetramethyl- 3- phenyl- fuco( 3, 4-e)-astriazine.

En blanding av 5,42 g 5,7-dihydro-5,5,7,7-tetrameyl-3-fenylfuro (3, 4-e)-as-trjazin-4-oksyd og 70 ml trietyibf osf it oppvarmes i nitrogenatmosfære i 18 timer til koking ved en badtemperatur A mixture of 5.42 g of 5,7-dihydro-5,5,7,7-tetramethyl-3-phenylfuro (3, 4-e)-as-triazine-4-oxide and 70 ml of triethyl phosphate is heated in a nitrogen atmosphere for 18 hours until boiling at a bath temperature

på 180°C. Deretter fjernes losningsmidlet i vakuum og resten omkrystallieeres fra vandig etanol. Det erholdte 5,7-dihydro-5, 5, 7, 7;.rtetrametyl-3-f enylf uro (3, 4-e) -as-triazin smelter ved 90-9l°C. at 180°C. The solvent is then removed in vacuo and the residue is recrystallized from aqueous ethanol. The obtained 5,7-dihydro-5,5,7,7,-tetramethyl-3-phenylfluoro(3,4-e)-as-triazine melts at 90-91°C.

Eksempel 5: 5, 7- dihydro- 5, 5, 7, 7- tetrametvl- 3- fenylfuro( 3, 4- e)-as- triazin. Example 5: 5,7-dihydro-5,5,7,7-tetramethyl-3-phenylfuro(3,4-e)-astriazine.

Til en lbsning av 0,271 g 5,7-dihydro-5,5,7, 7-tetrametyl-3-fenylfuro(3,4-e)-as-triazin-4-oksyd og 0,246 g syklohexen i 4 ml absolutt etanol tilsettes 10 mg 10% palladium-kull-katalysator og den erholdte blanding oppvarmes til koking under nitrogenatmosfære i 18 timer. Deretter frafiltreres katalysatoren og filtratet inndampes til tbrrhet.. Resten omkrystalliseres fra eter/hexan hvorved 5,7-dihydro-5,5,7,7-tetrametyl-3-fenylfuro(3,4-e)-as-triazin med smeltepunkt 90-91°C erholdes. To a solution of 0.271 g of 5,7-dihydro-5,5,7,7-tetramethyl-3-phenylfuro(3,4-e)-as-triazine-4-oxide and 0.246 g of cyclohexene in 4 ml of absolute ethanol is added 10 mg of 10% palladium-charcoal catalyst and the resulting mixture is heated to boiling under a nitrogen atmosphere for 18 hours. The catalyst is then filtered off and the filtrate is evaporated to dryness. The residue is recrystallized from ether/hexane, whereby 5,7-dihydro-5,5,7,7-tetramethyl-3-phenylfuro(3,4-e)-as-triazine with a melting point of 90 -91°C is obtained.

Ytterligere forbindelser med formel I, hvori X, R^ og ^ har den i den fblgende tabell angitte betydning, kan erholdes under anvendels e av fremgangsmåtene i de foregående eksempter under anvendelse av egnede utgangsforbindelser i omtrent ekvivalente mengder. Further compounds of formula I, in which X, R^ and ^ have the meaning indicated in the following table, can be obtained using the methods in the preceding examples using suitable starting compounds in approximately equivalent amounts.

Claims (1)

Fremgangsmåte for fremstilling av nye 5,5,7, 7-tetrametylfuro (3,4-e)-as-triaziner med formel I Process for the production of new 5,5,7,7-tetramethylfuro (3,4-e)-as-triazines of formula I hvori X står for where X stands for og og R2 er like eller forskjellige og i det enkelte tilfelle betyr hydrogen, fluor, klor, en alkylgruppe med 1-4 karbonatomer, en rettkjedet alkoksygruppe med 1-4 karbonatomer, amino, nitro eller trifluormetyl, med den betingelse at (I) hvis en av smbstituentene R^ og R2 betyr nitro har den annen av dissé substituenteneen annen betydning enn nitro eller trifluormetyl (II) hvis. en av substituentene R^ og R2 står for t-butyl eller trifluormetyl, står den annen av disse substituenter, hvis den Befinner seg på det nabostående karbonatom, ikke for fri fluormetyl eller t-butyl, (III) hvis en av substituentene R^ og R2 står for t-butyl, står den annen av disse substituenter, hvis den befinner seg på det nabostående karbonatom, ikke for nitro, kar axk terisertt ved ata) for fremstilling av forbindelse med formel Ia hvori R, og R2 har den ovennevnte betydning, omsettes en forbindelse med formel II and and R2 are equal or different and in the individual case means hydrogen, fluorine, chlorine, an alkyl group with 1-4 carbon atoms, a straight-chain alkoxy group with 1-4 carbon atoms, amino, nitro or trifluoromethyl, with the condition that (I) if one of the substituents R 1 and R 2 means nitro, the other of these substituents has a meaning other than nitro or trifluoromethyl (II) if. one of the substituents R 1 and R 2 stands for t-butyl or trifluoromethyl, the other of these substituents, if it is on the neighboring carbon atom, does not stand for free fluoromethyl or t-butyl, (III) if one of the substituents R 1 and R 2 stands for t-butyl, the other of these substituents, if it is on the neighboring carbon atom, does not stand for nitro, car axk terized by ata) for the preparation of compound of formula Ia in which R and R 2 have the above-mentioned meaning, a compound of formula II is reacted i en inert gassatmosfære med forbindelser med formel III in an inert gas atmosphere with compounds of formula III hvori R^ og R2 har den ovennevnte betydning og R^ står for metyl eller etyl, eller b) for fremstilling av forbindelser med formel Iaa hvori 1 står for hydrogen, fluor, klor, en alkylgruppe med 1-4 karbonatomer eller en rettkjedet alkoksygruppe med 1-4 karbonatomer eller står for amino, med den betingelse at R.^ 1 har en annen betydning enn t-butyl hvis den befinner seg på det til ncbtrogruppen nabostående karbonatom, ved at forbindelser med formel lab in which R 1 and R 2 have the above meaning and R 2 stands for methyl or ethyl, or b) for the preparation of compounds of formula Iaa in which 1 stands for hydrogen, fluorine, chlorine, an alkyl group with 1-4 carbon atoms or a straight-chain alkoxy group with 1-4 carbon atoms or stands for amino, with the condition that R.^ 1 has a meaning other than t-butyl if it is located on the carbon atom neighboring the ncbtro group, in that compounds of formula lab hvori R^ ' har den ovennevnte betydning, nitreres, eller c) for fremstilling av forbindelse med formel Ib wherein R^ ' has the above meaning, is nitrated, or c) for the preparation of compound of formula Ib hvori R^ og R- har den ovennevte betydning, reduseres N-oksydgruppen i forbindelsene med formel Ia .i inert gassatmosfære.in which R^ and R- have the above meaning, the N-oxide group in the compounds of formula Ia is reduced in an inert gas atmosphere.
NO751455A 1974-05-01 1975-04-23 NO751455L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46575974A 1974-05-01 1974-05-01
US49657874A 1974-08-12 1974-08-12

Publications (1)

Publication Number Publication Date
NO751455L true NO751455L (en) 1975-11-04

Family

ID=27041399

Family Applications (1)

Application Number Title Priority Date Filing Date
NO751455A NO751455L (en) 1974-05-01 1975-04-23

Country Status (18)

Country Link
JP (1) JPS50149696A (en)
AT (1) AT357545B (en)
BE (1) BE828548A (en)
CA (1) CA1033734A (en)
CH (1) CH617435A5 (en)
DD (1) DD119792A5 (en)
DE (1) DE2517994A1 (en)
DK (1) DK139301B (en)
ES (3) ES437214A1 (en)
FI (1) FI57416C (en)
FR (1) FR2269347B1 (en)
GB (1) GB1496709A (en)
HU (1) HU171171B (en)
IL (2) IL47192A (en)
NL (1) NL7504919A (en)
NO (1) NO751455L (en)
SE (1) SE7504692L (en)
SU (1) SU588919A3 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI62837C (en) * 1977-03-18 1983-03-10 Sandoz Ag FREQUENCY REQUIREMENT FOR THERAPEUTIC THERAPEUTIC PYRANO (4,3-E) -AS-TRIAZINER AND DERASE 4-OXIDER
CH644863A5 (en) * 1978-02-03 1984-08-31 Sandoz Ag AETHANOPYRANO- (4,3-E) -AS-TRIAZINE, THEIR PRODUCTION AND THE RELEASING AND SLEEPING INGREDIENTS CONTAINED THEREOF.

Also Published As

Publication number Publication date
CH617435A5 (en) 1980-05-30
GB1496709A (en) 1977-12-30
ES454312A1 (en) 1977-12-01
CA1033734A (en) 1978-06-27
IL47192A (en) 1978-04-30
FI57416C (en) 1980-08-11
IL47192A0 (en) 1975-07-28
HU171171B (en) 1977-11-28
SU588919A3 (en) 1978-01-15
AU8064075A (en) 1976-11-04
ES437214A1 (en) 1977-05-16
IL52763A0 (en) 1977-10-31
DK139301B (en) 1979-01-29
DK172775A (en) 1975-11-02
SE7504692L (en) 1975-11-03
FI751205A (en) 1975-11-02
AT357545B (en) 1980-07-10
NL7504919A (en) 1975-11-04
ATA332475A (en) 1979-12-15
FR2269347A1 (en) 1975-11-28
FR2269347B1 (en) 1978-08-18
JPS50149696A (en) 1975-11-29
DK139301C (en) 1979-07-02
ES454313A1 (en) 1977-12-01
FI57416B (en) 1980-04-30
BE828548A (en) 1975-10-29
DE2517994A1 (en) 1975-11-13
DD119792A5 (en) 1976-05-12

Similar Documents

Publication Publication Date Title
RU2137774C1 (en) Method of preparing 9-aminocamptotecine and sulfonyloxy-derivatives of 9-nitro-20(s)- camptotecine
Fodor et al. Acyl migration o→ n in the diastereomeric 2-aminocyclohexyl benzoates
Korotaev et al. Domino reaction of 3-nitro-2-(trifluoromethyl)-2H-chromenes with 2-(1-phenylalkylidene) malononitriles: synthesis of functionalized 6-(trifluoromethyl)-6H-dibenzo [b, d] pyrans and a rare case of [1, 5] sigmatropic shift of the nitro group
WO1994029310A1 (en) Process for asymmetric total synthesis of camptothecin
Nielsen et al. Synthetic routes to aminodinitrotoluenes
NO751455L (en)
CN113698409B (en) Multipurpose diazabicyclo compound, preparation method and application in synthetic drugs
Danikiewicz et al. The synthesis of 1H-, 3H-, and 5H-2-benzazepine derivatives in the reaction of bicyclic aromatic nitro compounds with dimethyl phosphite and amines in the basic conditions
Grol et al. Synthesis and neuroleptic activity of isomeric thieno [1, 4] benzothiazines
Umarov et al. Alkaloids of Thalictrum flavum: Structure of thalflavine
Uncuţa et al. Beckmann and cyclization reactions of δ-oxo-α, β-unsaturated ketoximes obtained from pyrylium salts and hydroxylamine. formation of 2-aryl (or alkyl) amino-4, 6-disubstituted pyrylium salts
Sollott Conversion of 2, 4, 6-trinitrobenzyl chloride to 2, 2', 4, 4', 6, 6'-hexanitrostilbene by nitrogen bases
Becker Addition of carbanions and metalorganic compounds to quinone methides
CN104860881A (en) Methods for synthesizing 8-(nitro methyl) quinoline compounds and 8-methylamino tetrahydroquinoline compounds
AU2006266025A1 (en) Alkenyldiarylmethanes, fused analogs and syntheses thereof
US3541151A (en) Preparation of tertiary-butylamino-benzophenones
US4782184A (en) Method for making ethynylated aromatic compounds
US4615842A (en) Method for making ethynylated aromatic compounds and a method for making nitronium trifluoromethanesulfonate
Duan et al. Facile synthesis of fused polyheterocycles containing trifluromethylated benzo [6, 7] chromeno [2, 3-c] pyrazoles via one-pot two-step MCRs
Viallon et al. Thermal and acid-catalysed sigmatropic rearrangements of allylamino-methoxy-1, 2-benzoquinones
US3689523A (en) Substituted haloalkanesulfonanilides
He et al. Study on the reactions of fluoroalkanesulfonyl azides with N-alkylindoles
Sawicki Polyfluoroacyl derivatives of carcinogenic and allied amines
Fukata et al. Cyclodienones. Part 6. Preparation of 4-azido-2, 4, 6-tri-t-butyl-cyclohexa-2, 5-dienone and its thermal, photo-, and acid-catalyzed decomposition
JPS5854158B2 (en) Synquinapyridothiadiagin